Colorectal cancer is one of the most prevalent cancers in the United States, with thousands of new cases diagnosed each year.
Early detection is crucial in improving survival rates, and screening tools like Cologuard provide a non-invasive method for identifying potential cases.
However, many individuals who receive a positive Cologuard test result are left wondering: what percentage of positive Cologuard tests are cancer?
Understanding the accuracy and limitations of the Cologuard test is essential for making informed health decisions.
While Cologuard is a convenient screening method, it is not a definitive diagnostic tool.
This article will explore how often a positive Cologuard test indicates cancer, the test's sensitivity and specificity, the role of follow-up colonoscopy, and what to do after receiving a positive result.
If you are searching for cancer testing near you, knowing the facts about screening methods and their effectiveness is essential.
This article will help clarify common concerns and guide you on the next steps.
What Is Cologuard and How Does It Work?
Cologuard is an FDA-approved, at-home stool-based test designed to screen for colorectal cancer and precancerous polyps.
It works by detecting abnormal DNA mutations and traces of blood in stool samples, which may indicate the presence of colorectal abnormalities.
Key Features of Cologuard:
- Non-invasive screening tool for colorectal cancer.
- Detects abnormal DNA and blood associated with cancer or polyps.
- Recommended for individuals aged 45 and older who are at average risk of colorectal cancer.
- Convenient at-home collection—patients send their stool sample to a lab for analysis.
- No need for bowel preparation, sedation, or medical facility visits.
Limitations of Cologuard:
- It is not a definitive diagnostic test; a positive result requires a colonoscopy for confirmation.
- False positives occur in about 50% of cases, leading to unnecessary follow-ups.
- False negatives may miss some precancerous polyps or early-stage cancers.
- Not suitable for high-risk individuals (family history of colorectal cancer, prior polyps, or inflammatory bowel disease).
Cologuard provides a convenient alternative to colonoscopy, but it should be used as a preliminary screening tool rather than a replacement for more comprehensive diagnostic methods.
What Percentage of Positive Cologuard Tests Indicate Cancer?

A positive Cologuard test means that DNA mutations or blood have been detected in the stool sample.
However, this does not necessarily confirm the presence of cancer. According to clinical studies:
- Approximately 4% of individuals who receive a positive Cologuard test have colorectal cancer.
- Around 45% of positive tests detect advanced precancerous polyps.
- The remaining 50% of positive results are false positives, meaning no cancer or significant abnormalities are found during follow-up testing.
These statistics indicate that while a positive Cologuard test raises a red flag, it does not mean a person has cancer.
The test is designed to detect any potential abnormalities, which can sometimes lead to false positives.
This is why a follow-up colonoscopy is required to confirm the results.
Understanding Cologuard's Accuracy: Sensitivity and Specificity
Cologuard is a highly sensitive screening test for colorectal cancer, meaning it is effective at detecting cancerous and precancerous changes.
However, its specificity—the ability to correctly identify individuals who do not have cancer—is lower, leading to false positives in some cases.
Cologuard's Sensitivity and Specificity Rates:
- 92% Sensitivity for Colorectal Cancer – This means the test correctly identifies 92 out of 100 individuals with colorectal cancer.
- 42% Sensitivity for Precancerous Polyps – The test is less effective at detecting polyps, which are often the early warning signs of colorectal cancer.
- 87% Specificity – About 13% of individuals without cancer may receive a false positive result, requiring unnecessary follow-up testing.
What These Numbers Mean:
- High sensitivity ensures that most colorectal cancers are detected.
- Lower specificity increases the likelihood of false positives, causing unnecessary anxiety.
- False negatives can also occur, meaning some people with early-stage cancer or small polyps may receive a negative result.
While Cologuard is an effective screening tool, a positive test result must always be confirmed with a colonoscopy to rule out false positives and provide an accurate diagnosis.
False Positives and False Negatives: What Do They Mean?
False Positives (When the Test Detects Cancer, But None Is Found)
A false positive occurs when a test result suggests the presence of cancer, but a follow-up colonoscopy does not confirm it.
Several factors can contribute to false positives in Cologuard testing, including:
- Non-cancerous bleeding in the digestive tract, such as from hemorrhoids or ulcers.
- Benign polyps that do not have the potential to become cancerous.
- Gastrointestinal conditions, such as inflammatory bowel disease (IBD), Crohn's disease, or colitis.
- Stool sample contamination or test processing errors.
False positives can cause unnecessary anxiety, but they also serve as an early warning, prompting individuals to undergo further testing to ensure they are cancer-free.
False Negatives (When the Test Misses Cancer)
A false negative occurs when a person with colorectal cancer receives a negative Cologuard result. While this is less common, it can happen due to:
- The cancer being in an early stage with minimal DNA shedding.
- The test missing small or non-bleeding polyps.
- Incorrect sample collection or processing errors.
Due to the possibility of false negatives, individuals with symptoms such as persistent changes in bowel habits, unexplained weight loss, or blood in the stool should follow up with a doctor, even if their Cologuard test is negative.
Cologuard vs. Colonoscopy: Which Is More Accurate?
Colonoscopy is the gold standard for colorectal cancer screening because it provides a direct view of the colon and allows for immediate polyp removal.
Compared to Cologuard, a colonoscopy offers:
- Higher accuracy in detecting both cancer and precancerous polyps.
- The ability to remove polyps immediately, reducing future cancer risk.
- Lower false positive and false negative rates.
| Feature | Cologuard | Colonoscopy |
| Cancer Detection Rate | ~92% | Nearly 100% |
| Precancerous Polyp Detection Rate | ~42% | 95%+ |
| False Positives | ~50% | Rare |
| Procedure Type | At-home stool test | In-clinic procedure |
| Follow-Up Required? | Yes, if positive | No, unless abnormalities are found |
While Cologuard is a convenient option, it is not a replacement for a colonoscopy, especially for individuals at higher risk of colorectal cancer.
What Should You Do After a Positive Cologuard Test?
If you receive a positive Cologuard test result, do not panic.
Since only 4% of positive results indicate cancer, further testing is required.
Here's what to do next:
- Schedule a Consultation with Your Doctor – Discuss your results, medical history, and potential risk factors.
- Undergo a Colonoscopy – This is the definitive way to determine whether cancer or precancerous polyps are present.
- Follow Recommended Screening Intervals – If your colonoscopy is clear, continue regular screenings based on your doctor's advice.
Ignoring a positive Cologuard result is not recommended, as it may indicate a precancerous condition that requires monitoring.
Where to Get Cancer Testing Near You?
For those looking for cancer testing near you, Premier Hematology and Oncology in New York offers comprehensive colorectal cancer screenings, genetic testing, and expert care.
Visit Premier Hematology and Oncology to schedule a consultation and ensure early detection and prevention.
Conclusion
A positive Cologuard test does not mean you have cancer, as only about 4% of positive results lead to a colorectal cancer diagnosis.
However, because the test detects abnormalities, follow-up with a colonoscopy is essential.
Understanding colorectal cancer screening methods can help individuals make informed decisions about their health.
If you are seeking cancer testing near you, working with a trusted healthcare provider ensures you receive accurate screening and proper medical guidance.
For expert care and colorectal cancer screening, visit Premier Hematology and Oncology today. Early detection can save lives.
Frequently Asked Questions (FAQs)
What percentage of positive Cologuard tests actually indicate cancer?
Approximately 4% of positive Cologuard tests indicate colorectal cancer. Around 45% of positive results detect advanced precancerous polyps, while the remaining 50% are false positives that do not indicate cancer or significant abnormalities. This is why a colonoscopy is required to confirm the results.
How accurate is Cologuard in detecting colorectal cancer?
Cologuard has a 92% sensitivity rate for detecting colorectal cancer, meaning it correctly identifies 92 out of 100 cases. However, its sensitivity for detecting precancerous polyps is lower (about 42%), which means it can miss early-stage polyps that could develop into cancer.
Can a positive Cologuard test be a false alarm?
Yes, false positives occur in about 50% of cases. Non-cancerous conditions such as hemorrhoids, benign polyps, inflammatory bowel disease, or minor bleeding in the digestive tract can cause a positive result. Because of this, a colonoscopy is necessary to confirm whether cancer or polyps are present.
What should I do if my Cologuard test is positive?
If your Cologuard test is positive, you should schedule a follow-up colonoscopy as soon as possible. A colonoscopy will provide a definitive diagnosis, allowing doctors to examine your colon and remove any precancerous polyps if needed. Do not ignore a positive result, as it may indicate early signs of colorectal abnormalities.
Is Cologuard a replacement for colonoscopy?
No, Cologuard is not a replacement for colonoscopy. While it is a good non-invasive screening tool for average-risk individuals, colonoscopy remains the gold standard for detecting and preventing colorectal cancer. Colonoscopy is more accurate, can detect small polyps, and allows for immediate removal of precancerous growths.